MedTrace Logo

OASIS Wound Matrix (Oasis) Mechanism of Action

NCT00570141 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2011-06-09

Study results available
· View outcomes & findings →

Summary

OASIS Wound Matrix (Oasis) will be applied to wounds, with sequential biopsy of healing wounds to explore the mechanism of action.

Conditions

  • Diabetic Foot Ulcers (DFU)
  • Venous Stasis Ulcers (VSU)

Interventions

DEVICE

OASIS Wound Matrix

OASIS (an acellular biomaterial that supports tissue repair with a scaffold-like matrix having a natural structure and composition).

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • W. Payne, M.D. · Bay Pines VA Healthcare System

  • Carl Van Gils, DPM, CWS · Dixie Regional Medical Center Wound Clinic

  • Davin Haraway, DO · Sparks Regional Medical Center

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00570141 on ClinicalTrials.gov